Welcome to CDC Stacks | A Comparison of Live Counseling with a Web-Based Lifestyle and Medication Intervention to Reduce Coronary Risk A Randomized Clinical Trial - 30088 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Comparison of Live Counseling with a Web-Based Lifestyle and Medication Intervention to Reduce Coronary Risk A Randomized Clinical Trial
Filetype[PDF - 1.73 MB]


Details:
  • Pubmed ID:
    24861959
  • Pubmed Central ID:
    PMC4142754
  • Description:
    Importance

    Most primary care clinicians lack the skills and resources to offer effective lifestyle and medication counseling to reduce coronary heart disease (CHD) risk. Thus, effective and feasible CHD prevention programs are needed for typical practice settings.

    Objective

    To assess the effectiveness, acceptability, and cost-effectiveness of a combined lifestyle and medication intervention to reduce CHD risk offered in counselor-delivered and web-based formats.

    Design

    Comparative effectiveness trial.

    Setting

    Five diverse family medicine practices in North Carolina.

    Participants

    Established patients, age 35–79, with no known cardiovascular disease, and at moderate to high risk for CHD -- 10 year Framingham Risk Score (FRS) ≥ 10%.

    Intervention

    Participants were randomized to counselor-delivered or web-based format, each including 4 intensive and 3 maintenance sessions. After randomization, both formats utilized a web-based decision aid showing potential CHD risk reduction associated with lifestyle and medication risk reducing strategies. Participants chose the risk reducing strategies they wished to follow.

    Main Outcome and Measures

    Outcomes were assessed at 4 and 12 months; the primary outcome was within group change in FRS at 4 month follow-up. Other measures included standardized assessments of blood pressure, blood lipids, lifestyle behaviors, and medication adherence. Acceptability and cost-effectiveness were also assessed.

    Results

    Of 2,274 screened patients, 385 were randomized (192 counselor; 193 web): mean age 62 years, 24% African American, and mean FRS 16.9%. Follow-up at 4 and 12 months was 91% and 87%, respectively. There was a sustained reduction in FRS at both 4 (primary outcome) and 12 month follow-up: for counselor, −2.3% (95% CI: −3.0% to −1.6%) and −1.9% (−2.8% to −1.1%) and for web, −1.5% (−2.2% to −0.9%) and −1.7%, (−2.6% to −0.8%) respectively. At 4 month follow-up, the adjusted difference in FRS between groups was −1.0% (95% CI −1.8% to −0.1%, p = 0.03) at 12 month follow-up, it was −0.6% (95% CI, −1.7% to 0.5%, p = 0.30). The 12 month costs from the payer perspective were $207 and $110 per person for the counselor and web interventions respectively.

    Conclusions and Relevance

    Both intervention formats reduced CHD risk through 12 month follow-up. The web format was less expensive.

  • Document Type:
  • Collection(s):
  • Funding:
    1U48DP002658/DP/NCCDPHP CDC HHS/United States
    P30 DK056350/DK/NIDDK NIH HHS/United States
    P30 DK093002/DK/NIDDK NIH HHS/United States
    P30DK056350/DK/NIDDK NIH HHS/United States
    U48/DP001944/DP/NCCDPHP CDC HHS/United States
    UL1 TR001111/TR/NCATS NIH HHS/United States
No Related Documents.
You May Also Like: